Area of research
Immunology · Oncology
Research interest
Research interests include Cell biology, Biology, Ubiquitin ligase, Cancer research, Acetylation, and Histone.
NAC1 promotes stemness and regulates myeloid-derived cell status in triple-negative breast cancer
eEF2K promotes PD-L1 stabilization through inactivating GSK3β in melanoma
The endoplasmic reticulum–resident E3 ubiquitin ligase Hrd1 controls a critical checkpoint in B cell development in mice
Immunotherapy for triple-negative breast cancer: Existing challenges and exciting prospects
The Histone Acetyltransferase Gcn5 Positively Regulates T Cell Activation
Development and characterization of naive single-type tumor antigen-specific CD8<sup>+</sup> T lymphocytes from murine pluripotent stem cells
TGF-β–Induced Regulatory T Cells Directly Suppress B Cell Responses through a Noncytotoxic Mechanism
The ER membrane-anchored ubiquitin ligase Hrd1 is a positive regulator of T-cell immunity
Endoplasmic reticulum-resident E3 ubiquitin ligase Hrd1 controls B-cell immunity through degradation of the death receptor CD95/Fas
Deleted in Breast Cancer 1 Suppresses B Cell Activation through RelB and Is Regulated by IKKα Phosphorylation
USP22 Antagonizes p53 Transcriptional Activation by Deubiquitinating Sirt1 to Suppress Cell Apoptosis and Is Required for Mouse Embryonic Development